Severe Aortic Root Dilatation in Infantile Marfan Syndrome

Overview

Journal Proc (Bayl Univ Med Cent)

Specialty General Medicine

Date 2019 Oct 29

PMID 31656420

Authors

Renita A Thomas

Chikamuche T Anyanwu

Maria Blazo

Saradha Subramanian

Affiliations

Soon will be listed here.

Abstract

Cardiovascular manifestations of Marfan syndrome are associated with increased mortality, especially in the pediatric population. Early recognition is critical to long-term management. We present two cases of genetically defined "classical" Marfan syndrome presenting with severe infantile aortic root dilatation among siblings and discuss options for therapy.

References

LeBlanc S, Taranath D, Morris S, Barnett C . Multisegment coloboma in a case of Marfan syndrome: another possible effect of increased TGFβ signaling. J AAPOS. 2014; 18(1):90-2. DOI: 10.1016/j.jaapos.2013.10.017. View

Shimizu H, Kasahara H, Nemoto A, Yamabe K, Ueda T, Yozu R . Can early aortic root surgery prevent further aortic dissection in Marfan syndrome?. Interact Cardiovasc Thorac Surg. 2011; 14(2):171-5. PMC: 3279987. DOI: 10.1093/icvts/ivr035. View

Stuart A, Williams A . Marfan's syndrome and the heart. Arch Dis Child. 2007; 92(4):351-6. PMC: 2083669. DOI: 10.1136/adc.2006.097469. View

Thakur V, Rankin K, Hartling L, Mackie A . A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome. Cardiol Young. 2012; 23(4):568-81. DOI: 10.1017/S1047951112001412. View

Beroud C, Hamroun D, Collod-Beroud G, Boileau C, Soussi T, Claustres M . UMD (Universal Mutation Database): 2005 update. Hum Mutat. 2005; 26(3):184-91. DOI: 10.1002/humu.20210. View

Romaniello F, Mazzaglia D, Pellegrino A, Grego S, Fiorito R, Ferlosio A . Aortopathy in Marfan syndrome: an update. Cardiovasc Pathol. 2014; 23(5):261-6. DOI: 10.1016/j.carpath.2014.04.007. View

Peng Q, Deng Y, Yang Y, Liu H . A novel fibrillin-1 gene missense mutation associated with neonatal Marfan syndrome: a case report and review of the mutation spectrum. BMC Pediatr. 2016; 16:60. PMC: 4852411. DOI: 10.1186/s12887-016-0598-6. View

Groenink M, den Hartog A, Franken R, Radonic T, de Waard V, Timmermans J . Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J. 2013; 34(45):3491-500. DOI: 10.1093/eurheartj/eht334. View

Ware A, Miller D, Erickson L, Menon S . Marfan syndrome associated aortic disease in neonates and children: a clinical-morphologic review. Cardiovasc Pathol. 2016; 25(5):418-22. DOI: 10.1016/j.carpath.2016.06.002. View

10.

Heo J, Song J, Choi E, Kim E, Kim J, Park S . Atypical Neonatal Marfan Syndrome with p.Glu1073Lys Mutation of FBN1: the First Case in Korea. J Korean Med Sci. 2016; 32(1):1-3. PMC: 5143279. DOI: 10.3346/jkms.2017.32.1.1. View

11.

Habashi J, Judge D, Holm T, Cohn R, Loeys B, Cooper T . Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006; 312(5770):117-21. PMC: 1482474. DOI: 10.1126/science.1124287. View

12.

Carande E, Bilton S, Adwani S . A Case of Neonatal Marfan Syndrome: A Management Conundrum and the Role of a Multidisciplinary Team. Case Rep Pediatr. 2017; 2017:8952428. PMC: 5266800. DOI: 10.1155/2017/8952428. View

13.

Ewans L, Roberts P, Ades L . Losartan therapy for cardiac disease in paediatricMarfan syndrome. J Paediatr Child Health. 2015; 51(9):927-31. DOI: 10.1111/jpc.12823. View